4th Quarter - Amendment

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$243,029
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 17, 2020 $243,029 Replaced
4th Quarter - Amendment (this page) Apr 21, 2020 $243,029 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

The 340B Drug Pricing Program; FY 2020 L-HHS Appropriations, S. 1895, Lower Health Care Costs Act, H.R. 3, Lower Drug Costs Now Act of 2019, S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019.

LobbyistCovered position, as disclosed
ELISE CRANSTON —
KATHRYN DIBITETTO —
GREG DOGGETT —
AMANDA SELLERS SMITH —
MAUREEN TESTONI —

Contacted: SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), S. 1895 (116th), H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.